These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3917961)

  • 21. [Mass screening for colorectal cancer--issues and future prospects].
    Kobayashi S
    Gan No Rinsho; 1984 May; 30(6 Suppl):611-5. PubMed ID: 6748232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult-blood screening for colorectal carcinoma: the benefits.
    Frank JW
    Am J Prev Med; 1985; 1(3):3-9. PubMed ID: 3916713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer screening.
    Bharath S
    JAMA; 1979 Jul; 242(2):140. PubMed ID: 448878
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemoquant--an approach to screening for fecal occult blood.
    McGill DB; Ahlquist DA
    Prog Clin Biol Res; 1985; 186():45-56. PubMed ID: 4034605
    [No Abstract]   [Full Text] [Related]  

  • 26. Value of a risk questionnaire in screening for colorectal neoplasm.
    Kewenter J; Haglind E; Smith L
    Br J Surg; 1989 Mar; 76(3):280-3. PubMed ID: 2720326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer screening in average risk individuals.
    Huang CS; Lal SK; Farraye FA
    Cancer Causes Control; 2005 Mar; 16(2):171-88. PubMed ID: 15868457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for colorectal cancer.
    Robinson MH; Berry DP; Vellacott KD; Moshakis V; Hardcastle JD
    Lancet; 1993 Jul; 342(8865):241. PubMed ID: 8100960
    [No Abstract]   [Full Text] [Related]  

  • 29. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
    Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
    Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economics of screening for colo-rectal cancer.
    Kristein MM
    Soc Sci Med Med Econ; 1980 Dec; 14C(4):275-84. PubMed ID: 6781069
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult.
    Thomas WM; Pye G; Hardcastle JD; Walker AR
    Br J Surg; 1992 Aug; 79(8):833-5. PubMed ID: 1393487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemical detection of fecal occult blood--the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer.
    Songster CL; Barrows GH; Jarrett DD
    Cancer; 1980 Mar; 45(5 Suppl):1099-102. PubMed ID: 6965607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for colorectal cancer: the issues.
    Winawer S; Schottenfeld D; Sherlock P
    Gastroenterology; 1985 Mar; 88(3):841-4. PubMed ID: 3917962
    [No Abstract]   [Full Text] [Related]  

  • 34. [Does prolonging the test period improve screening for colorectal cancer?].
    Hammes PH; Gnauck R
    Z Gastroenterol; 1987 Sep; 25(9):607-11. PubMed ID: 3673146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for colorectal cancer using the Hemoccult II stool guaiac slide test.
    Cummings KM; Michalek A; Mettlin C; Mittelman A
    Cancer; 1984 May; 53(10):2201-5. PubMed ID: 6704908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening for cancer of the large intestine].
    Gnauck R
    Wien Med Wochenschr; 1988 Jun; 138(11-12):257-60. PubMed ID: 3051684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
    Verne J; Kettner J; Mant D; Farmer A; Mortenson N; Northover J
    Eur J Cancer Prev; 1993 Jul; 2(4):301-5. PubMed ID: 8358281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.